AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E401170-T1: [Translated] METHOD AND SYSTEM FOR ALLOWING INCREASED ACCURACY IN MULTIPLE CONNECTED ROBOTS BY CALCULATION OF THE KINEMATIC ROBOT MODEL PARAMETERS

A method and system to provide improved accuracies in multi jointed robots through kinematic robot model parameters determination are disclosed. The present invention calibrates multi-jointed robots by using the chain rule for differentiation in the Jacobian derivation for variations in calculated poses of reference points of a reference object as a function of variations in robot model parameters. The present invention also uses two such reference objects and the known distance therebetween to establish a length scale, thus avoiding the need to know one link length of the robot. In addition, the present invention makes use of iterative methods to find the optimum solution for improved accuracy of the resultant model parameters. Furthermore, the present invention provides for determination of the end joint parameters of the robot, including parameters defining the tool attachment mechanism frame, which allows for interchange of tools without subsequent calibration.
Patent AT-E401338-T1: [Translated] CITRULLINE PEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY AUTOANTIBODIES SPECIFIC TO RHEUMATOID ARTHRITIS AND THE USE THEREOF

The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognizable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample.
COVID-19 State Profile Report - Iowa

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Compound 528167: 1,3-Cyclopentadiene, 1-heptyl

Chemical compound data from PubChem database. IUPAC Name: 1-heptylcyclopenta-1,3-diene. Molecular Formula: C12H20. Molecular Weight: 164.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530075: Trimethylsilyl 2-oxopentanoate

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-oxopentanoate. Molecular Formula: C8H16O3Si. Molecular Weight: 188.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525471: 4,6-Dithia-1-heptene

Chemical compound data from PubChem database. IUPAC Name: 3-(methylsulfanylmethylsulfanyl)prop-1-ene. Molecular Formula: C5H10S2. Molecular Weight: 134.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Self-medication and non-doctor prescription practices in Pokhara valley, Western Nepal: a questionnaire-based study

Background
          Self-medication and non-doctor prescribing of drugs is common in developing countries. Complementary and alternative medications, especially herbs, are also commonly used. There are few studies on the use of these medications in Pokhara Valley, Western Nepal.
        
        
          Methods
          Previously briefed seventh semester medical students, using a semi-structured questionnaire, carried out the study on 142 respondents. Demographic information and information on drugs used for self-medication or prescribed by a non-allopathic doctor were collected.
        
        
          Results
          Seventy-six respondents (54%) were aged between 20 to 39 years. The majority of the respondents (72 %) stayed within 30 minutes walking distance of a health post/medical store. 59% of these respondents had taken some form of self-medication in the 6-month period preceding the study. The common reasons given for self-medication were mild illness, previous experience of treating a similar illness, and non-availability of health personnel. 70% of respondents were prescribed allopathic drugs by a non-allopathic doctor. The compounder and health assistant were common sources of medicines. Paracetamol and antimicrobials were the drugs most commonly prescribed. A significantly higher proportion of young (<40 years) male respondents had used self-medication than other groups.
        
        
          Conclusions
          Self-medication and non-doctor prescribing are common in the Pokhara valley. In addition to allopathic drugs, herbal remedies were also commonly used for self-medication. Drugs, especially antimicrobials, were not taken for the proper duration. Education to help patients decide on the appropriateness of self-medication is required.
Compound 530158: m-Methoxycinnamic acid trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3-(3-methoxyphenyl)prop-2-enoate. Molecular Formula: C13H18O3Si. Molecular Weight: 250.36. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529928: Dehydro nimodipine

Chemical compound data from PubChem database. IUPAC Name: 5-O-(2-methoxyethyl) 3-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Molecular Formula: C21H24N2O7. Molecular Weight: 416.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526175: Dimethyl 4-methylphenyl phosphate

Chemical compound data from PubChem database. IUPAC Name: dimethyl (4-methylphenyl) phosphate. Molecular Formula: C9H13O4P. Molecular Weight: 216.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526277: 1,3,7,8-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,7,8-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2015 CMHS Uniform Reporting System (URS) Table for North Carolina

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for North Carolina.  The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Hospital Cost Report Edited Data: 2010

The Institutional Cost Report (ICR) is a uniform report completed by New York hospitals to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations, (Part 86-1.2), Article 28 hospitals are required to file financial and statistical data with DOH annually. The data filed is part of the ICR and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends. The ICR is a comprehensive compilation of exhibits that have been modified over time that users should consider when using the ICR dataset. It is possible that data is updated subsequent to posting on this website; therefore the data could become obsolete. To get the details related to the exhibits and data elements, please refer to the blank ICR form, the ICR Table of Contents, the ICR Instructions and the Glossary of Terms, Acronyms, and Abbreviations which are in the Supporting Information section of this site. The data posted as edited contains desk edit adjustments by DOH personnel. In 2009, this information was not audited; however effective with the 2010 ICR, all ICRs will be audited by a Certified Public Accounting Firm annually.
Compound 528037: Benzoic acid, 4-nitro, 1,2-dimethylpropyl ester

Chemical compound data from PubChem database. IUPAC Name: 3-methylbutan-2-yl 4-nitrobenzoate. Molecular Formula: C12H15NO4. Molecular Weight: 237.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401385-T1: [Translated] AQUEOUS COMPOSITIONS CONTAINING VESICLES WITH A CERTAIN VESICLE PERMEABILITY

Compositions for effectively delivering a water-soluble active material to a surface comprise: (a) from about 1% to about 30%, by weight of the composition, of a dialkyl quaternary ammonium compound having the formula: wherein R1 and R2 are independently C12 to C20 saturated alkyl chains; Y is wherein R4 is ethyl or isopropyl; R3 and R5 are independently methyl, ethyl, hydroxyethyl, or hydroxypropyl; m is 1, 2, or 3; n is 1 or 2; p is 0 or 1; and X- is a suitable anion; (b) from about 0.01% to about 10%, by weight of the composition, of water-soluble active material having a ClogP of less than about 2.0; and (c) at least about 60%, by weight of the composition, of water; wherein the compositions contain vesicles having a vesicle permeability index of less than about 1.3. Processes to make the compositions comprise the steps of dispersing the dialkyl quaternary ammonium compound and the water-soluble active material in an aqueous solution to form vesicles having a vesicle permeability index of less than about 1.3.
Compound 528582: Propanedioic acid, bis(tert-butyldimethylsilyl) ester

Chemical compound data from PubChem database. IUPAC Name: bis[tert-butyl(dimethyl)silyl] propanedioate. Molecular Formula: C15H32O4Si2. Molecular Weight: 332.58. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Comparison of NSDUH Mental Health Data and Methods with Other Data Sources

This report compares estimates of adult mental health from the 2009 National Survey on Drug Use and Health (NSDUH) with estimates of similar measures from 2001 to 2003 National Comorbidity Survey Replication (NCS-R), 2001 to 2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), 2007 Behavioral Risk Factor Surveillance System (BRFSS), 2008 National Health Interview Survey (NHIS), 2008 Medical Expenditure Panel Survey (MEPS), and 2008 Uniform Reporting System (URS).
Evolution of gene fusions: horizontal transfer versus independent events

Background
          Gene fusions can be used as tools for functional prediction and also as evolutionary markers. Fused genes often show a scattered phyletic distribution, which suggests a role for processes other than vertical inheritance in their evolution.
        
        
          Results
          The evolutionary history of gene fusions was studied by phylogenetic analysis of the domains in the fused proteins and the orthologous domains that form stand-alone proteins. Clustering of fusion components from phylogenetically distant species was construed as evidence of dissemination of the fused genes by horizontal transfer. Of the 51 examined gene fusions that are represented in at least two of the three primary kingdoms (Bacteria, Archaea and Eukaryota), 31 were most probably disseminated by cross-kingdom horizontal gene transfer, whereas 14 appeared to have evolved independently in different kingdoms and two were probably inherited from the common ancestor of modern life forms. On many occasions, the evolutionary scenario also involves one or more secondary fissions of the fusion gene. For approximately half of the fusions, stand-alone forms of the fusion components are encoded by juxtaposed genes, which are known or predicted to belong to the same operon in some of the prokaryotic genomes. This indicates that evolution of gene fusions often, if not always, involves an intermediate stage, during which the future fusion components exist as juxtaposed and co-regulated, but still distinct, genes within operons.
        
        
          Conclusion
          These findings suggest a major role for horizontal transfer of gene fusions in the evolution of protein-domain architectures, but also indicate that independent fusions of the same pair of domains in distant species is not uncommon, which suggests positive selection for the multidomain architectures.
Compound 529639: Methyl 11-methyl-6-methylidene-16-oxo-5,14-bis(trimethylsilyloxy)-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

Chemical compound data from PubChem database. IUPAC Name: methyl 11-methyl-6-methylidene-16-oxo-5,14-bis(trimethylsilyloxy)-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate. Molecular Formula: C26H42O6Si2. Molecular Weight: 506.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease

NNDSS - TABLE 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease  – 2020.  In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 530311: Tyr, N-TFA

Chemical compound data from PubChem database. IUPAC Name: 2,2,2-trifluoro-N-[1-(4-hydroxyphenyl)-3-oxopropan-2-yl]acetamide. Molecular Formula: C11H10F3NO3. Molecular Weight: 261.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NSDUH 2018 Sample Design Report

This report details the 2018 sample design for the NSDUH and covers the design overview, target population, and stages of sample selection. The design overview describes how the sample design remains consistent with NSDUH’s designs since 1991 and has extended coverage of the sample since then to include additional resident populations. The 2018 target population for this report comprises a civilian, noninstitutionalized population aged 12 years or older residing within the 50 states and the District of Columbia. There are three stages of sample selection that are explained in terms of how to select and aggregate the appropriate census tracts and segments based on state sampling regions (SSRs) for each state.
Dependence, Abuse, and Treatment Tables (Prevalence Estimates) - 5.1 to 5.56

These detailed tables present totals and prevalence estimates of substance dependence/abuse and treatment need/receipt from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Results are provided by age group, gender, race/ethnicity, education level, employment status, and geographic area. Comparisons are made between 2012 and 2011.
Preferred Language Spoken in California Facilities

The dataset contains combined counts for hospital discharges, emergency room encounters, and ambulatory surgeries by preferred language spoken at each facility. The nearly 100 languages collected in the patient-level data were combined into eight geographical or cultural groups: English Language, Spanish Language, Asian/Pacific Islander Languages, Middle Eastern Languages, European Languages, African Languages, Latin American Languages, Native American Languages, and Sign Language. See the Preferred Language Spoken Language List below to see the exact separation of languages.
2013 CMHS Uniform Reporting System Output Tables

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Table 21. Needing But Not Receiving Treatment for Illicit Drug Use in the Past Year, by Age Group and State: Percentages, Annual Averages Based on 2010 and 2011 NSDUHs

This report presents State estimates for measures of needing but not receiving treatment for past year illicit drug use based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Resuts are provided by age group.
Compound 529019: 1-Ethyl-3-methyl-4-propylbenzene

Chemical compound data from PubChem database. IUPAC Name: 4-ethyl-2-methyl-1-propylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526273: 1,3,6,8-Tetrabromo-2,9-dichloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1,3,6,8-tetrabromo-2,9-dichlorodibenzo-p-dioxin. Molecular Formula: C12H2Br4Cl2O2. Molecular Weight: 568.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Heart rate changes during partial seizures: A study amongst Singaporean patients

Introduction
          Studies in Europe and America showed that tachycardia, less often bradycardia, frequently accompanied partial seizures in Caucasian patients. We determine frequency, magnitude and type of ictal heart rate changes during partial seizures in non-Caucasian patients in Singapore.
        
        
          Methods
          Partial seizures recorded during routine EEGs performed in a tertiary hospital between 1995 and 1999 were retrospectively reviewed. All routine EEGs had simultaneous ECG recording. Heart rate before and during seizures was determined and correlated with epileptogenic focus. Differences in heart rate before and during seizures were grouped into 4 types: (1) >10% decrease; (2) -10 to +20% change; (3) 20–50% increase; (3) >50% increase.
        
        
          Results
          Of the total of 37 partial seizures, 18 were left hemisphere (LH), 13 were right hemisphere (RH) and 6 were bilateral (BL) in onset. 51% of all seizures showed no significant change in heart rate (type 2), 22% had moderate sinus tachycardia (type 3), 11% showed severe sinus tachycardia (type 4), while 16% had sinus bradycardia (type 1). Asystole was recorded in one seizure. Apart from having more tachycardia in bilateral onset seizures, there was no correlation between side of ictal discharge and heart rate response. Compared to Caucasian patients, sinus tachycardia was considerably less frequent. Frequency of bradycardia was similar to those recorded in the literature.
        
        
          Conclusions
          Significant heart rate changes during partial seizures were seen in half of Singaporean patients. Although sinus tachycardia was the most common heart rate change, the frequency was considerably lower compared to Caucasian patients. This might be due to methodological and ethnic differences. Rates of bradycardia are similar to those recorded in the literature.
Tribal Consultation on Title IV-E Information Systems Regulations

This report provides a summary of a formal consultation process with tribes regarding the Statewide and Tribal Automated Child Welfare Information System (SACWIS/TACWIS), including comments and questions raised by tribal leaders and representatives, the responses from Children’s Bureau staff, and the intended follow-up by the Division of State Systems.

Metadata-only record linking to the original dataset. Open original dataset below.